ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,282,800 | +44.8% | 235,376 | +78.3% | 0.00% | – |
Q2 2023 | $885,882 | -77.5% | 132,024 | -70.3% | 0.00% | – |
Q1 2023 | $3,930,895 | +264.1% | 445,175 | +215.0% | 0.00% | – |
Q4 2022 | $1,079,716 | -9.4% | 141,324 | -15.6% | 0.00% | – |
Q3 2022 | $1,192,000 | -13.7% | 167,377 | -1.9% | 0.00% | – |
Q2 2022 | $1,381,000 | -52.5% | 170,675 | -18.5% | 0.00% | – |
Q1 2022 | $2,908,000 | -55.5% | 209,475 | -10.1% | 0.00% | -100.0% |
Q4 2021 | $6,534,000 | +2.1% | 232,888 | +23.7% | 0.00% | 0.0% |
Q3 2021 | $6,398,000 | -20.5% | 188,248 | -4.4% | 0.00% | 0.0% |
Q2 2021 | $8,050,000 | +37.9% | 197,001 | +35.9% | 0.00% | 0.0% |
Q1 2021 | $5,836,000 | -34.5% | 144,971 | -3.8% | 0.00% | 0.0% |
Q4 2020 | $8,914,000 | +13.6% | 150,749 | -6.6% | 0.00% | 0.0% |
Q3 2020 | $7,847,000 | -8.2% | 161,380 | -8.7% | 0.00% | 0.0% |
Q2 2020 | $8,552,000 | +129.7% | 176,793 | +31.9% | 0.00% | 0.0% |
Q1 2020 | $3,723,000 | -34.0% | 134,002 | -28.9% | 0.00% | 0.0% |
Q4 2019 | $5,638,000 | +666.0% | 188,431 | +690.1% | 0.00% | – |
Q3 2019 | $736,000 | – | 23,849 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
Triatomic Management LP | 102,889 | $560,745 | 0.39% |